
Publications
How Can We Optimise Health Technology Assessment and Reimbursement Decisions to Accelerate Access to New Cardiovascular Medicines?
Martin R. Cowie, Biykem Bozkurt, Javed Butler, Andrew Briggs, Maria Kubin, Adrian Jonas, Amanda I. Adler, Bray Patrick-Lake, Faiez Zannad
This paper builds on discussions among clinical trialists, industry representatives, regulators, and patients, which took place at the 17th Global Cardiovascular Clinical Trialists (CVCT) Forum in December 2020.
Source:
International Journal of Cardiology